Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bromelain for primary dysmenorrhea pain
IRCT20160813029327N23Phase 3Completed
- Sponsor
- Salamat Parmoon Amin
- Start
- Aug 2024
- Modality
- Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of bromelain in primary dysmenorrhea (PD), sponsored by Salamat Parmoon Amin. Primary endpoint: Menstrual pain intensity. Started Aug 2024; status: completed.
02
Drugs
bromelain
03
Conditions
primary dysmenorrhea (PD)
Beyond the preview
Go deeper on IRCT20160813029327N23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160813029327N23.